Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04624633 |
|---|---|
| Brief Title: | Acalabrutinib, Umbralisib, and Ublituximab (AU2) In Relapsed and Untreated CLL |
| First Submitted : | November 5, 2020 |
| First Submitted that Met QC Criteria : | November 5, 2020 |
| First Posted : | November 12, 2020 |
| Last Update Submitted that Met QC Criteria : | March 18, 2024 |
| Last Update Posted : | March 19, 2024 |